11-Keto Fusidic Acid

Catalog No. :
ACAZTX075
CAS No. :
16711-91-4
Molecular Formula :
C31H46O6
Molecular Weight :
514.70

IUPAC Name:(Z)-2-((3R,4S,5S,8S,9S,10S,13R,14S,16S)-16-acetoxy-3-hydroxy-4,8,10,14-tetramethyl-11-oxohexadecahydro-17H-cyclopenta[a]phenanthren-17-ylidene)-6-methylhept-5-enoic acid

11-Keto Fusidic Acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$1120.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name11-Keto Fusidic Acid
IUPAC Name(Z)-2-((3R,4S,5S,8S,9S,10S,13R,14S,16S)-16-acetoxy-3-hydroxy-4,8,10,14-tetramethyl-11-oxohexadecahydro-17H-cyclopenta[a]phenanthren-17-ylidene)-6-methylhept-5-enoic acid
Molecular FormulaC31H46O6
Molecular Weight514.70
SMILESCC(=O)O[C@H]1C[C@@]2(C)[C@@H](CC(=O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O
InChI KeyRLYFYROONDDGHK-DMLPZSAWSA-N
Synonym11-monoketofusidic acid;11-Keto Fusidic Acid;(3α,4α,8α,9β,13α,14β,16β,17Z)-16-(Acetyloxy)-3-hydroxy-11-oxo-;Fusidic Acid BP ImpurityH;Sodium Fusidate Impurity 8(Sodium Fusidate EP Impurity H);Fusidic Acid Impurity H;11-Ketofusidinsaeure;Fusidic Acid EP Impurity H
CAS No.16711-91-4

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301+H311+H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311-P361+P364-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAZTX075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAZTX075 route product structure diagram
    ACAZTX07516711-91-4
Inquiry

2. ACAZTX075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAZTX075 route product structure diagram
    ACAZTX07516711-91-4
Inquiry

Comments (0)